Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT01799460 |
Date of registration:
|
08/01/2013 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy
|
Scientific title:
|
Mechanism Research of Traditional Chinese Medicine (the Comprehensive Treatment Regimen) in Treating Idiopathic Membranous Nephropathy by Genomewide Association Studies |
Date of first enrolment:
|
December 2010 |
Target sample size:
|
80 |
Recruitment status: |
Recruiting |
URL:
|
http://clinicaltrials.gov/show/NCT01799460 |
Study type:
|
Observational |
Study design:
|
Observational Model: Cohort, Time Perspective: Retrospective
|
Phase:
|
N/A
|
|
Countries of recruitment
|
China
| | | | | | | |
Contacts
|
Name:
|
Wang Lin, PHD |
Address:
|
|
Telephone:
|
86-13816583673 |
Email:
|
happytlynn@163.com |
Affiliation:
|
|
|
Name:
|
Wang Lin, PHD |
Address:
|
|
Telephone:
|
86-13816583673 |
Email:
|
happytlynn@163.com |
Affiliation:
|
|
|
Name:
|
Wang Lin, PHD,MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Shanghai University of Traditional Chinese Medicine |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Clinical diagnosis of idiopathic membranous nephropathy
- Chronic Kidney Disease (CKD)=3 stage(Glomerular Filtration Rate (GFR)=30ml/min)and 24
hour urinary protein=3g
- Voluntarily participated in the study and signed an informed consent
Exclusion Criteria:
- Combined life-threatening complications such as serious infection
- Abnormal glucose metabolism
- Patients with malignant tumors or malignancy , HIV infection and a history of mental
illness , acute central nervous system disease , serious gastrointestinal
diseases,etc
- Pregnancy or breast-feeding women
- Undergoing other clinical trials
Age minimum:
18 Years
Age maximum:
70 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Idiopathic Membranous Nephropathy
|
Intervention(s)
|
Drug: The immunosuppressive agents
|
Drug: The Comprehensive Treatment Regimen of Traditional Chinese Medicine
|
Primary Outcome(s)
|
Genome-wide single-nucleotide-polymorphism of IMN patients treated by the Comprehensive Treatment Regimen or conventional approach
[Time Frame: one year]
|
Secondary ID(s)
|
11YZ65
|
ShanghaiMEC-2011
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|